The need for a consistent definition of 'aspirin resistance' [1]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 7, 2006, Pages 1618-1619

  Violi, Fracesco ^a   Pignatelli, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THROMBOXANE A2;

ASPIRIN RESISTANCE; CARDIOVASCULAR DISEASE; CONSENSUS; DRUG MECHANISM; DRUG RESISTANCE; DRUG RESPONSE; ENZYME INACTIVATION; EX VIVO STUDY; HUMAN; LABORATORY TEST; LETTER; MEDICAL RESEARCH; NOMENCLATURE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELIABILITY; SAMPLE SIZE; THROMBOCYTE FUNCTION; TREATMENT FAILURE; URINARY EXCRETION;

ASPIRIN; CONSENSUS; DRUG RESISTANCE; TERMINOLOGY;

EID: 33745241084     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02007.x     Document Type: Letter

References (12)

1. Rocca B, Patrono C. Determinants of the interindividual variability in response to antiplatelet drugs. J Thromb Haemost 2005; 3: 1597-602.
2. Mason PJ, Jacobs AK, Freedman JE. Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol 2005; 46: 986-93.
3. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: An emerging clinical entity. Eur Heart J 2006; 27: 647-54.
4. Szczeklik A, Musial J, Undas A, Sanak M. Aspirin resistance. J Thromb Haemost 2005; 3: 1655-62.
5. Sanderson S, Emery J, Baglin T, Kinmonth AL. Narrative review: Aspirin resistance and its clinical implications. Ann Intern Med 2005; 142: 370-80.
6. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-17.
7. Violi F, Pignatelli P, Pulcinelli FM. Aspirin. J Thromb Haemost 2004; 2: 338-9.
8. Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, Fitzgerald DJ. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol 2005; 46: 1258 -63
9. Pulcinelli FM, Riondino S, Celestini A, Pignatelli P, Trifiro E, Di Renzo L, Violi F. Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin. J Thromb Haemost 2005; 3: 2784-9.
10. Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005; 46: 1705-9.
11. Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, DeFranco A. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 2005; 95: 973-5.
12. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5.